Richard Wade-Martins

Richard Wade-Martins

OPDC Principal Investigator

OPDC Theme 2 Leader

Richard leads the Oxford Parkinson's Disease Centre (OPDC), established with the £5m Monument Trust Discovery Award from Parkinson's UK. Richard also leads the OPDC theme to generate improved cellular and genetic models of Parkinson's (Theme 2).

Richard works on molecular mechanisms of neurodegenerative diseases, heading the Molecular Neurodegeneration Research Laboratory and the Oxford Parkinson’s Disease Centre. He plays a leading role in the IMI StemBANCC program using stem cells for drug discovery and heads the iPSC Dementia Stem Cell Initiative in the Dementia Platform UK.

Richard's work consequently has two main interests: studying the molecular mechanisms of neurodegenerative diseases such as Parkinson's and related disorders, and developing novel viral and nonviral gene expression vectors as potential therapies.

In the OPDC Richard will be generating the new transgenic rat and mouse models of Parkinson's and studying the cell biology of dopamine neurons.

  Watch Professor Wade-Martins discussing our research:

Drug and Target Discovery in Parkinson's

OPDC Participants' Day

May 2016

How can skin cells help us understand Parkinson's?

OPDC Participants' Day

March 2015

Clinical Trials and Parkinson's: What does it take to find a cure?

Parkinson's UK Clinical Trials Lectures at the Royal Institution

November 2013


A question and answer session on clinical trials and Parkinson's

Parkinson's researchers Dr Alan Whone and Dr Richard Wade-Martins are joined by Dr Katie Le Blond from Parkinson's UK for a question and answer session on clinical trials and Parkinson's.

November 2013